Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Metformin and COVID-19: From cellular mechanisms to reduced mortality133
Patients with diabetes are at higher risk for severe illness from COVID-19115
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports107
Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis99
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment87
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients84
Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials79
Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes69
A systematic review of nudge theories and strategies used to influence adult health behaviour and outcome in diabetes management57
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-1957
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes57
Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: Results from the CORONADO study56
Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms55
Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study52
Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes46
Elevated triglyceride–glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study41
Meat and fish intake and type 2 diabetes: Dose–response meta-analysis of prospective cohort studies39
Smoking and diabetes interplay: A comprehensive review and joint statement35
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-1934
Glucose variability and diabetes complications: Risk factor or biomarker? Can we disentangle the “Gordian Knot”?33
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies32
Is the type 2 diabetes epidemic plateauing in France? A nationwide population-based study32
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations31
Fulminant type 1 diabetes after COVID-19 vaccination29
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-1927
Triglyceride–glucose index associates with incident heart failure: A cohort study27
Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction26
Diabetes mellitus in the era of climate change26
Liraglutide and sitagliptin have no effect on intestinal microbiota composition: A 12-week randomized placebo-controlled trial in adults with type 2 diabetes26
Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials25
Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease25
The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview24
Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD24
Targeting ageing and preventing organ degeneration with metformin23
Diabetic ketoacidosis and mortality in COVID-19 infection23
Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Dia22
Practical implementation of automated closed-loop insulin delivery: A French position statement22
The gut microbiota and diabetic cardiomyopathy in humans22
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study21
Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes20
The association between gestational diabetes mellitus and cancer in women: A systematic review and meta-analysis of observational studies20
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?19
Cardiovascular risks of periodontitis and oral hygiene indicators in patients with diabetes mellitus19
Eye disorders other than diabetic retinopathy in patients with diabetes19
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement19
Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement19
Lower limb amputations: protection with GLP-1 receptor agonists rather than increased risk with SGLT2 inhibitors?19
COVID-19 symptoms masking inaugural ketoacidosis of type 1 diabetes18
Three alternative ways to screen for hyperglycaemia in pregnancy during the COVID-19 pandemic17
The diuretic effects of SGLT2 inhibitors: A comprehensive review of their specificities and their role in renal protection17
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study17
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study17
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors16
Associations of serum magnesium levels and calcium–magnesium ratios with mortality in patients with coronary artery disease16
Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial16
Serum uric acid in early pregnancy and risk of gestational diabetes mellitus: A cohort study of 85,609 pregnant women16
Determinants of aspirin resistance in patients with type 2 diabetes16
SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?16
Five-year mortality in patients with diabetic foot ulcer during 2009–2010 was lower than expected16
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study15
Association between sleep duration in early pregnancy and risk of gestational diabetes mellitus: a prospective cohort study15
Lower trabecular bone score in type 2 diabetes mellitus: A role for fat mass and insulin resistance beyond hyperglycaemia15
Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study15
Association of hyperglycaemia with hospital mortality in nondiabetic COVID-19 patients: A cohort study15
The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients15
Antidiabetic agents and risk of atrial fibrillation/flutter: A comparative critical analysis with a focus on differences between SGLT2 inhibitors and GLP-1 receptor agonists15
Insulin sensitivity improvement with exercise training is mediated by body weight loss in subjects with metabolic syndrome15
Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells15
Euglycaemic ketoacidosis during gestational diabetes with concomitant COVID-19 infection15
Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria14
Challenging 2019 ESC guidelines for the management of type 2 diabetes14
Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study14
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis14
Fasting plasma glucose variability in midlife and risk of Parkinson's disease: A nationwide population-based study13
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan13
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort13
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass12
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function12
SGLT2 inhibition increases serum copeptin in young adults with type 1 diabetes12
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes12
Dietary sodium and potassium and risk of diabetes: A prospective study using data from the China Health and Nutrition Survey12
Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis12
Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin11
Glycaemic variabilities: Key questions in pursuit of clarity11
Impact of gender on relative rates of cardiovascular events in patients with diabetes11
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes11
Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study11
Liraglutide 3 mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma10
Gender and age differences in the association between sleep characteristics and fasting glucose levels in Chinese adults10
Efficacy of semaglutide versus liraglutide in clinical practice10
Acute renal injury events in diabetic patients treated with SGLT2 inhibitors: A comprehensive review with a special reference to RAAS blockers10
0.023637771606445